Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice
Open Access
- 10 August 2024
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-12
Abstract
Mutations in fibrillin 1 (FBN1) is the main cause of Marfan syndrome (MFS) with thoracic aortic aneurysm (TAA) as the main complication. Activation of the complement system plays a key role in the formation of thoracic and abdominal aortic aneurysms. However, the role of the complement system in MFS-associated aortic aneurysms remains unclear. In this study, we observed increased levels of complement C3a and C5a in the plasma of MFS patients and mouse, and the increased deposition of the activated complement system product C3b/iC3b was also observed in the elastic fiber rupture zone of 3-month-old MFS mice. The expression of C3a receptor (C3aR) was increased in MFS aortas, and recombinant C3a promoted the expression of cytokines in macrophages. The administration of a C3aR antagonist (C3aRA) attenuated the development of thoracic aortic aneurysms in MFS mice. The increased inflammation response and matrix metalloproteinases activities were also attenuated by C3aRA treatment in MFS mice. Therefore, these findings indicate that the complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice.Keywords
This publication has 44 references indexed in Scilit:
- Allopurinol blocks aortic aneurysm in a mouse model of Marfan syndrome via reducing aortic oxidative stressFree Radical Biology and Medicine, 2022
- Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trialsThe Lancet, 2022
- Fibroblast-Secreted Phosphoprotein 1 Mediates Extracellular Matrix Deposition and Inhibits Smooth Muscle Cell Contractility in Marfan Syndrome Aortic AneurysmJournal of Cardiovascular Translational Research, 2022
- Role of complement system in pathological remodeling of the vascular wallMolecular Immunology, 2019
- Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan SyndromeJACC, 2018
- Novel mechanisms and functions of complementNature Immunology, 2017
- NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s DiseaseNeuron, 2015
- Update of the UMD-FBN1mutation database and creation of anFBN1polymorphism databaseHuman Mutation, 2003
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002
- Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin geneNature, 1991